METAP2 INHIBITORS AND METHODS OF TREATING OBESITY
Application
US20260076960A1
Kind: A1
Mar 19, 2026
Inventors
James SHANAHAN, John S. PETERSEN
Abstract
The present invention relates to modified or polymer conjugated MetAP2 inhibitors. The present invention also relates to methods of preventing, inducing, causing or increasing weight loss, treating obesity and/or treating metabolic syndrome utilizing the modified or polymer conjugated MetAP2 inhibitors. The present invention also relates to methods of improving insulin sensitivity and glycemic control, reducing insulin levels and/or improving leptin sensitivity utilizing the modified or polymer conjugated MetAP2 inhibitors.
CPC Classifications
A61K 31/485
A61K 31/336
A61K 31/77
A61K 47/542
A61K 47/58
A61K 47/65
A61P 3/04
A61P 3/08
A61P 3/10
A61P 5/50
Filing Date
2025-04-21
Application No.
19184440